الصفحة 1
الصفحة 1
Frontiers in Anti-Infective Drug Discovery ; Vol.9
Covers a range of topics including rational drug design and drug discovery, medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships. Frontiers in Anti-Infective Drug Discovery is a valuable resource for pharmaceutical scientists and post-graduate students seeking updated and critically important information for developing clinical trials and devising research plans in this field. The ninth volume of this series features 5 reviews that cover some aspects of clinical and pre-clinical antimicrobial drug development, with 2 chapters focusing on drugs to treat leishmaniasis and dengue fever, respectively. - Use of preclinical and early clinical data for accelerating antimicrobial drug development - Post-translational modifications: host defence mechanism, pathogenic weapon, and emerged target of anti-infective drugs - Scope and limitations on the potent antimicrobial activities of hydrazone derivatives - Current scenario of anti-leishmanial drugs and treatment - Dengue hemorrhagic fever: the potential repurposing drugs
Crimean-Congo Hemorrhagic Fever : A Global Perspective
Crimean-Congo hemorrhagic fever (CCHF) is a tick-borne disease associated with severe hemorrhagic manifestations. CCHF has been referred to as the "Asian Ebola." However, in fact, the disease is one of the most widely distributed tick-borne diseases in the world, occurring in Africa, Asia, Europe, and the Middle East. This volume covers major aspects of this important disease and the virus which causes it. Chapters are written by leading experts in their fields and detail historical, public health, epidemiological, and clinical aspects of CCHF and the genetics and molecular biology of the virus. Additional chapters focus on disease control, tick vectors and infection among animals, both natural and experimental.
Biological, chemical, and radiological Terrorism : Emergency preparedness and response for the primary care physician
This book provides sought-after guidance to primary care physicians on preparing for and responding to terrorist events. Chapters offer a fundamental understanding of the epidemiology and relevant clinical aspects of diseases caused by biological agents (anthrax, plague, smallpox, botulism, tularemia, and hemorrhagic viruses), chemical agents (nerve and blister), and radiological agents. The text details how to detect terrorist-caused illness as early as possible, how to provide defensive or preventive therapy, and how to triage and treat ill patients. Emphasis is placed on addressing both the physical and psychological impact on patients and providers.
